Literature DB >> 24212185

An evidence-based analysis of Australian optometrists' dry eye practices.

Laura E Downie1, Peter R Keller, Algis J Vingrys.   

Abstract

PURPOSE: The aims of this study were to investigate the clinical practices of Australian optometrists as related to the diagnosis, quantification, and management of dry eye and to assess whether these are consistent with research evidence and current guidelines.
METHODS: An online survey was distributed to registered optometrists (n = 654). Respondents provided information regarding their preferred diagnostic procedures and management strategies for dry eye, practice modality, year of commencing practice, and whether they possessed an interest in dry eye.
RESULTS: Respondents (n = 144) used multiple procedures for diagnosis. Recording patient symptoms ranked as the most important, most valuable, and most commonly used technique. The main objective tests were fluorescein-assisted tear breakup time, corneal fluorescein staining, and meibomian gland evaluation. Optometrists with an interest in dry eye more frequently used lissamine green, phenol red test, interference fringes, and tear osmolarity than nonspecialist practitioners. Dry eye treatment varied with severity. The mainstay of therapy was nonpreserved lubricants and eyelid hygiene; more practitioners recommended topical corticosteroids, systemic omega-3 fatty acid supplementation and increased dietary intake of omega-3 fatty acids for moderate and severe disease, respectively. The primary sources of information used to guide practitioners' management were derived from continuing education conferences.
CONCLUSIONS: This study indicates that although Australian optometrists use subjective and objective diagnostic tests and stratify treatment based on dry eye severity, there is a lack of uniformity regarding diagnostic testing, infrequent use of standardized grading scales, and significant variability in clinical care. These findings highlight the potential to improve the translation of dry eye research evidence and evidence-based guidelines into Australian optometric practice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24212185     DOI: 10.1097/OPX.0000000000000087

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  10 in total

1.  Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.

Authors:  Laura E Downie; Sueko M Ng; Kristina B Lindsley; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2019-12-18

2.  Influence of Omega 3 and 6 Fatty Acids on Human Meibomian Gland Epithelial Cells.

Authors:  Yang Liu; Wendy R Kam; David A Sullivan
Journal:  Cornea       Date:  2016-08       Impact factor: 2.651

3.  The self-reported clinical practice behaviors of Australian optometrists as related to smoking, diet and nutritional supplementation.

Authors:  Laura Elizabeth Downie; Peter Richard Keller
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

4.  Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study.

Authors:  Jordi Gatell-Tortajada
Journal:  Clin Interv Aging       Date:  2016-05-19       Impact factor: 4.458

5.  Optical Coherence Tomography Reveals Changes to Corneal Reflectivity and Thickness in Individuals with Tear Hyperosmolarity.

Authors:  Laura Adelaide Deinema; Algis Jonas Vingrys; Holly Rose Chinnery; Laura Elizabeth Downie
Journal:  Transl Vis Sci Technol       Date:  2017-05-22       Impact factor: 3.283

Review 6.  An Evidence-Based Strategic Approach to Prevention and Treatment of Dry Eye Disease, a Modern Global Epidemic.

Authors:  Pragnya R Donthineni; Swapna S Shanbhag; Sayan Basu
Journal:  Healthcare (Basel)       Date:  2021-01-17

Review 7.  Trends in Dry Eye Disease Management Worldwide.

Authors:  Mohamed Mostafa Hantera
Journal:  Clin Ophthalmol       Date:  2021-01-14

8.  TheraPearl Eye Mask and Blephasteam for the treatment of meibomian gland dysfunction: a randomized, comparative clinical trial.

Authors:  Jonatan Olafsson; Xiaoran Lai; Erlend Christoffer Sommer Landsend; Snorri Olafsson; Eric Parissi; Øygunn A Utheim; Sten Raeder; Reza A Badian; Neil Lagali; Darlene A Dartt; Tor P Utheim
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

Review 9.  Tear instability importance, mechanisms, validity and reliability of assessment.

Authors:  Charles W Mcmonnies
Journal:  J Optom       Date:  2018-01-11

10.  Systematic review of the appropriateness of eye care delivery in eye care practice.

Authors:  Kam Chun Ho; Fiona Stapleton; Louise Wiles; Peter Hibbert; Sally Alkhawajah; Andrew White; Isabelle Jalbert
Journal:  BMC Health Serv Res       Date:  2019-09-06       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.